Menu
Recruiting NCT06917339

Retrospective Analyses of TrakStar Database

— Observational Depression Obsessive-Compulsive Disorder Anxiety Depression

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: NeuroStar Advanced TMS Therapy System.
Who it may be relevant to
Registry conditions: Depression, Obsessive-Compulsive Disorder, Anxiety Depression. Basic parameters: 5 years — 120 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Retrospective Analyses Evaluating the Real-World Effectiveness of NeuroStar® TMS and the Factors Associated With Clinical Outcomes

Overview

In this study, real-world data will be used to better understand the effects patient characteristics, symptoms and TMS protocol parameters have on clinical outcomes with NeuroStar TMS.

Interventions

  • Device NeuroStar Advanced TMS Therapy System
    non-invasive brain stimulation device

Primary outcome measures

  • Change in clinical assessment score from baseline to post-treatment [Time frame: 8 weeks]
Secondary outcome measures (1)
  • Age at baseline and its correlation to change in score post treatment [Time frame: 8 weeks]

Eligibility criteria

Inclusion criteria

  • Male or female reported in database and not an invalid entry
  • Age reported and not an invalid entry
  • Treatment date of November 01, 2008 or later.

Exclusion criteria

  • Incomplete information on treatment parameters

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Cohort

Study locations

United States · 1 center
  • Neuronetics — Malvern

Identifiers

NCT: NCT06917339 · 11-10000-000

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗